 |
Current Management Opportunities for Improving Patient Outcomes in Rheumatoid Arthritis CME Kathryn F. Hobbs, MD Author Information and Disclosures Release Date: January 9, 2008; Valid for credit through January 9, 2009 | Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s)™ for physicians | | The content of this CME activity, "Current Management Opportunities for Improving Patient Outcomes in Rheumatoid Arthritis," was developed by the faculty.
The Coalition of Rheumatology Educators (CORE) initiative is designed to enhance rheumatologists' awareness of the need for early diagnosis and aggressive management of rheumatoid arthritis (RA) and to better objectify assessment of disease activity, potentially leading to remission. Clinical experts in the field of rheumatology are working with the American Academy of CME, Inc and Princeton CME to develop educational content based on the latest published and presented data on early RA diagnosis and aggressive management, to incorporate that content into live, print, and web based CME programming, and to assess participant learning and ongoing educational needs.
To participate in this activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details. Contents of This CME Activity Legal DisclaimerThe material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity. Copyright © 2008 Princeton CME, a division of Princeton Media Associates, LLC. |
|
|
Learning Objectives Upon completion of this activity, participants should be able to: - Employ current data on the clinical benefits and limitations of biologic therapies in the management of RA and related diseases;
- Identify the role of
new therapies in the treatment of RA and related conditions;
- Assess the potential benefits of early diagnosis and aggressive management of RA and related diseases, including the prospect of achieving remission;
- Develop methods for properly evaluating remission in RA and related diseases, while altering management approaches based on therapeutic response;
- Recognize the connection between uncontrolled RA and the
development of comorbid conditions;
- Incorporate evidence-based approaches for the prevention and management of treatment adverse effects and comorbidities of RA and related diseases.
Author Disclosures Kathryn Hobbs, MD
Associate Clinical Professor of
Medicine, University of Colorado Denver; Director, Clinical Trials Unit, Denver Arthritis Clinic, Denver, Colorado
Disclosure: Advisory Board: Centocor, Genentech, Inc, Wyeth Pharmaceuticals; Scientific Advisory Board: Centocor, Genentech, Inc, Wyeth Pharmaceuticals; Speakers Bureau: Abbott Laboratories, Amgen Inc, Bristol-Myers Squibb Company, Centocor, Genentech, Inc, Wyeth Pharmaceuticals. James Katz,
MD
Independent, Clinical Reviewer
Associate Professor of Medicine; Director, Division of Rheumatology, The George Washington University, Washington, DC
Disclosure: No relevant financial relationships to disclose. Planning Committee: Debra Bottinick, American Academy of CME, Inc, and Randy Robbin, John Savage, and Richard Michael Tyska, PharmD, of Princeton CME have
disclosed no relevant financial relationships with any commercial interests. John Juchniewicz, American Academy of CME, Inc: Stockholder: Johnson & Johnson. Instructions for Participation and Credit There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your
professional licensing board. This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. Follow these steps to earn CME/CE credit*:
- Read the target audience, learning objectives, and author disclosures.
- Study the educational content online or printed out.
- Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score of 70% or more. In addition, you must complete the Activity Evaluation to provide feedback for future programming.
You may now view or print the certificate from your
CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage. *The credit that you receive is based on your user profile.
|
 |
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the American Academy of CME, Inc and Princeton CME. The American Academy of CME, Inc is accredited by the ACCME to provide continuing medical education for physicians.
The American Academy of CME, Inc designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Contact This Provider
|
|
